CLINACIN 150 MG ANTIBIOTIC TABLETS FOR DOGS

Nazione: Australia

Lingua: inglese

Fonte: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Principio attivo:

CLINDAMYCIN AS CLINDAMYCIN HYDROCHLORIDE

Commercializzato da:

CHANELLE PHARMACEUTICALS MANUFACTURING LIMITED

INN (Nome Internazionale):

clindamycin as HCl(150mg/Tb)

Forma farmaceutica:

ORAL TABLET

Composizione:

CLINDAMYCIN AS CLINDAMYCIN HYDROCHLORIDE ANTIBIOTIC Active 150.0 mg/Tb

Confezione:

100 Tabs; 50 Tablets

Classe:

VM - Veterinary Medicine

Prodotto da:

CHANELLE PHARMACEUTI

Gruppo terapeutico:

DOG | BITCH | CASTRATE | PUPPY

Area terapeutica:

ANTIBIOTIC & RELATED

Indicazioni terapeutiche:

ACTINOMYCES SPP. | BACTEROIDES SPP. | CLOSTRIDIUM SPP. | DENTAL INFECTION | FUSOBACTERIUM SPP. | OSTEOMYELITIS | PEPTOSTREPTOCOCCUS SPP. | PROPIONIBACTERIUM SPP. | STAPHYLOCOCCUS AUREUS | STAPHYLOCOCCUS SPP. | STREPTOCOCCUS SPP. | WOUND INFECTIONS | ABSCESSES | ANAEROBIC BACTERIA | CLOSTRIDIUM BOTULINUM | CLOSTRIDIUM CHAUVOEI | CLOSTRIDIUM FALLAX | CLOSTRIDIUM FESERI | CLOSTRIDIUM HEMOLYTICUM | CLOSTRIDIUM NOVYI | CLOSTRIDIUM PERFRINGENS TYPES | CLOSTRIDIUM SEPTICUM | CLOSTRIDIUM SORDELLI | CLOSTRIDIUM SPOROGENES | CLOSTRIDIUM TETANI | INCLUDING B-LACTAMASE PRODUCIN | STAPHYLOCOCCOSIS

Dettagli prodotto:

Poison schedule: 4; Withholding period: WHP: N/A.; Host/pest details: DOG: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., OSTEOMYELITIS, PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ACTINOMYCES SPP., BACTEROIDES SPP., CLOSTRIDIUM SPP., DENTAL INFECTION, FUSOBACTERIUM SPP., OSTEOMYELITIS, PEPTOSTREPTOCOCCUS SPP., PROPIONIBACTERIUM SPP., STAPHYLOCOCCUS AUREUS, STAPHYLOCOCCUS SPP., STREPTOCOCCUS SPP., WOUND INFECTIONS]; For the treatment of infected wounds, abscesses, dental infections and osteomyelitis in dogs where these infections are caused by bacteria susceptible to clindamycin.Contraindicated in rabbits, hamsters & guinea pigs and in other sensitive animals. Should not be used in cats for longer than 2 weeks. RESTRAINT: DO NOT USE in food producing species of animals or horses.

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2023-07-01

Foglio illustrativo

LABEL IMAGE PROUDLY SUPPLIED BY
[e-mail]

Scheda tecnica

PRODUCT NAME: CLINACIN ANTIBIOTIC TABLETS FOR DOGS AND CATS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
clindamycin is an antibiotic ingredient.
TRADE NAME:
CLINACIN ANTIBIOTIC TABLETS FOR DOGS AND CATS
PRODUCT CODE:
18934, 18935 and 18936
RECOMMENDED USE:
Antibiotic for treatment of dogs and cats (prescription animal
remedy).
APVMA NO:
57882, 57884, 57885
CREATION DATE:
June, 2007
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
S22, S25, S45. Do not breathe dust. Avoid contact with eyes. In case
of accident or if you feel
unwell, contact a doctor or Poisons Information Centre immediately
(show this MSDS where possible).
SUSDP CLASSIFICATION:
S4
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
A round or oblong white tablet with a breakline on one side.
ODOUR:
No data.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product. The
active ingredient is an
antibiotic. Any person with a history of allergies to this class of
substances should avoid all contact with this product as it
may cause sensitisation.
Adverse reactions associated with clindamycin treatment include:
diarrhoea, pseudomembranous colitis, nausea,
vomiting, abdominal pain/cramps, rash, and/or itch.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSU